NASDAQ: JAGX
Jaguar Health Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their JAGX stock forecasts and price targets.

Forecast return on equity

Is JAGX forecast to generate an efficient return?

Company
-84.08%
Industry
10,538.19%
Market
230.57%
JAGX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is JAGX forecast to generate an efficient return on assets?

Company
-19.57%
Industry
4,297.59%
JAGX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

JAGX earnings per share forecast

What is JAGX's earnings per share in the next 2 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.06-112.48%
Avg 2 year Forecast
-$0.97-105.88%

JAGX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
JAGX$0.86N/AN/A
XTLB$1.85N/AN/A
BCDA$2.19$25.00+1,041.55%Buy
APLM$9.33N/AN/A
ENSC$7.58N/AN/A

Jaguar Health Stock Forecast FAQ

What is JAGX's earnings growth forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 53.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 59.2%.

Jaguar Health's earnings in 2025 is -$37,742,000.On average, 1 Wall Street analyst forecast JAGX's earnings for 2025 to be -$24,304,473, with the lowest JAGX earnings forecast at -$24,304,473, and the highest JAGX earnings forecast at -$24,304,473.

In 2026, JAGX is forecast to generate -$11,444,339 in earnings, with the lowest earnings forecast at -$11,444,339 and the highest earnings forecast at -$11,444,339.

If you're new to stock investing, here's how to buy Jaguar Health stock.

What is JAGX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: JAGX) forecast ROE is -84.08%, which is considered weak.

What is JAGX's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: JAGX) Jaguar Health's current Earnings Per Share (EPS) is $16.51. On average, analysts forecast that JAGX's EPS will be -$2.06 for 2025, with the lowest EPS forecast at -$2.06, and the highest EPS forecast at -$2.06. In 2026, JAGX's EPS is forecast to hit -$0.97 (min: -$0.97, max: -$0.97).

What is JAGX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: JAGX) forecast ROA is -19.57%, which is lower than the forecast US Biotechnology industry average of 4,297.59%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.